Versant Venture Capital III, L.P.'s Net Worth
$30.5 Million
Who is Versant Venture Capital III, L.P.?
Versant Venture Capital III, L.P. has an estimated net worth of $30.5 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., PHASERX, INC., Trius Therapeutics Inc, Flexion Therapeutics Inc, VERACYTE, INC., OCULAR THERAPEUTIX, INC, OPGEN INC, and Skye Bioscience, Inc..
SEC CIK
Versant Venture Capital III, L.P.'s CIK is 0001456586
Past Insider Trading and Trends
2014 was Versant Venture Capital III, L.P.'s most active year for acquiring shares with 10 total transactions. Versant Venture Capital III, L.P.'s most active month to acquire stocks was the month of June. 2014 was Versant Venture Capital III, L.P.'s most active year for disposing of shares, totalling 12 transactions. Versant Venture Capital III, L.P.'s most active month to dispose stocks was the month of June. 2014 saw Versant Venture Capital III, L.P. paying a total of $6,776,514.00 for 8,395,559 shares, this is the most they've acquired in one year. In 2015 Versant Venture Capital III, L.P. cashed out on 742,616 shares for a total of $16,337,552.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNE DESIGN CORP. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.21M |
$12.00 | -$2,500,008.00 | 2.21M |
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PHASERX, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +21.36% | 341.96K |
$2.51 | $2,997,419.56 | 1.94M |
May 23
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trius Therapeutics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.24M |
$4.72 |
—
| 3.24M |
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Flexion Therapeutics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.35% | 714.28K |
$14.00 | $9,999,990.00 | 3.53M |
Jun 8
| |||
Form 4
|
∞
| 2.25K |
$17.61 | $39,622.50 | 2.25K |
Sep 10
| |||
Form 4
|
∞
| 2.25K |
$17.61 | $39,622.50 | 2.25K |
Sep 10
| |||
Form 4
| +19.56% | 3.1M |
$13.00 | $3,999,996.00 | 18.95M |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VERACYTE, INC. (VCYT) Snapshot price: $28.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.62M |
—
|
—
| 3.62M |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||